Product Information
PREDNISONE 2.5 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0661 per EA under NDC 59651048501. Its NADAC has been published 183 times since Apr 5, 2023.
FDA first approved this application on Mar 28, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651048501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PREDNISONEApproval Type
Generic (ANDA)
FDA Application
ANDA215672FDA Approved
3/28/2022
TE Code
AB
On Market Since
3/28/2022
Pharmacological Classes
Price Statistics
The NADAC for PREDNISONE 2.5 MG TABLET has been published 183 times since Apr 5, 2023, and over the history we have for it it has declined 16.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0661 per EA |
|---|---|
| All-time high | $0.0911 (Jan 10, 2024) |
| All-time low | $0.0501 (Jul 17, 2024) |
| 52-week high | $0.0775 |
| 52-week low | $0.0661 |
| Median price | $0.0729 |
| Average price | $0.0727 |
| Largest weekly change | -32.4% (Apr 17, 2024) |
| Weeks tracked | 183 |
| Tracking since | Apr 5, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
PREDNISONE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PREDNISONE 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PREDNISONE 2.5 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0661 per EA (NDC 59651048501), effective Sep 30, 2026.
How has the price of PREDNISONE 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for PREDNISONE 2.5 MG TABLET has declined 16.8%. It has been tracked across 183 weekly CMS publications since Apr 5, 2023.
What are the highest and lowest recorded NADAC prices for PREDNISONE 2.5 MG TABLET?
Since Apr 5, 2023, the NADAC for PREDNISONE 2.5 MG TABLET has ranged from a low of $0.0501 (Jul 17, 2024) to a high of $0.0911 (Jan 10, 2024), with a median of $0.0729 per EA.
Are there cheaper alternatives to PREDNISONE 2.5 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as PREDNISONE 2.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures PREDNISONE 2.5 MG TABLET?
PREDNISONE 2.5 MG TABLET (NDC 59651048501) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.